A world-leading ‘drug discovery’ conference was held at The King’s Centre, Oxford this week.
The inaugural ELRIG CRISPR in Drug Discovery: From Targets to Therapeutics was held at the convention centre in Osney Mead, Oxford.
Industry experts from the USA, France and Germany were among the line-up of keynote speakers. The scientific conference focussed on insights into solutions for increasing the success of drug discovery and development, via genome engineering technologies.
More than 300 delegates attended the two-day conference which brought together the research community from the world of academia, biotech and industry. The event included talks, lab-based workshops, an innovation forum and speakers’ dinner.
Tim King, General Manager at The King’s Centre, said: “ELRIG CRISPR is a significant conference in the life sciences community and we are proud to be hosting such an inspiring and market-leading event.”
Steve Rees, ELRIG UK Chairman said: “Hosting this event in Oxford forms part of the Golden Triangle for Biotech companies, following previous events in London and Cambridge. The event brings together the life science community and engages with researchers, academics and industry to collaborate in this vital area of scientific development.”
ELRIG, The European Laboratory Research and Innovation Group, is a UK-based not-for-profit organisation and leaders in the provision of scientific meetings and conferences.
The King’s Centre is the largest event and conference space in Oxford and the south Midlands with more than 30,000 square feet of space. It has two large convention halls and 10 support rooms.
All the profits from the centre, which is a ten-minute walk from Oxford train station, are used to support charitable projects.